Felix Bachmann
18Patents
2h-index
16Co-inventors
51Inventor score
Filing activity: Oct 23, 1998 → Nov 20, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8802858B2 | Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmune diseases | Human Necessities | 5 | Active |
| US7385061B2 | Furazanobenzimidazoles | Chemistry; Metallurgy | 2 | Expired |
| USRE42890E1 | Furazanobenzimidazoles | General | 2 | Expired |
| US10006078B2 | Use of phospho-Akt as a biomarker of drug response | Physics | 1 | Active |
| US6713305B1 | Metastasis-associated antigen and antibodies thereto | Physics | 1 | Expired |
| US8486996B2 | Aroylfuranes and aroylthiophenes | Human Necessities | 1 | Active |
| US9476889B2 | Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazoles | Physics | 1 | Active |
| US7423157B2 | Substituted benzimidazoles and their use for inducing apoptosis | Chemistry; Metallurgy | 1 | Active |
| US9970938B2 | Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles | Physics | 1 | Active |
| US10067120B2 | Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazoles | Physics | 1 | Active |
| US9995754B2 | Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles | Physics | 1 | Active |
| US9366682B2 | Use of stathmin as a biomarker of drug response to furazanobenzimidazoles | Physics | 1 | Active |
| US8288421B2 | Phenylaminopyridines | Chemistry; Metallurgy | 0 | Active |
| US11419856B2 | Pharmaceutical combinations for use in the treatment of neoplastic diseases | Human Necessities | 0 | Active |
| US10724072B2 | Use of phospho-Akt as a biomarker of drug response | Physics | 0 | Active |
| US7951957B2 | Substituted benzimidazoles and their use for inducing apoptosis | Chemistry; Metallurgy | 0 | Active |
| US10656162B2 | Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles | Physics | 0 | Active |
| US10222377B2 | Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.